According to data from the Ministry of Health (SS) , a total of 36.1 million influenza vaccines and 22.9 million SARS-CoV-2 vaccines will be administered from October 15, 2024, to March 28, 2025. This high demand for vaccines is accompanied by an increase in the means of transport for their transfer, which must be properly prepared to ensure the integrity of immunizations for the population.
It is known that the most important link for the success of vaccination campaigns is precisely the cold chain , which must be kept intact throughout the process because a minimal fluctuation in temperature can compromise the effectiveness of the product, with health and economic risks.
“Keeping the cold chain intact is essential, as even the slightest fluctuation in temperature can compromise the efficacy of vaccines. We are in a key time for the logistics of medicines and vaccines. To take advantage of this opportunity, companies must be prepared, paying special attention to monitoring the temperature during the transport of these products,” said Carlos Humberto Infante y Loya, founder and president of the Board of Directors for Kryotec .
To ensure the preservation of vaccines in the cold chain, Infante y Loya said it is important to constantly monitor the temperature to have control from the point of origin to the final destination.
“These actions allow for real-time monitoring of the conditions inside the containers, so that if any deviation from the recommended temperature ranges is detected, immediate action can be taken to prevent product loss,” he said.
He explained that proper management of the cold chain protects the investments of pharmaceutical companies and distributors, and strengthens society’s confidence in the effectiveness of vaccination campaigns.
The company spokesperson said that ensuring the quality of vaccines through continuous temperature monitoring and planned logistics is essential to meet the challenges of the winter season, guaranteeing that critical products arrive in the best possible condition and contributing to the general well-being of the population.
Temperature-sensitive vaccines, such as influenza and SARS-CoV-2, require specific storage and transport conditions, since they may lose their effectiveness outside the recommended temperature range.
“In addition to putting the product’s effectiveness at risk, temperature fluctuations during transport represent a potential economic loss for companies and a risk of shortages at a critical time,” Infante y Loya said.
Comment and follow us on X: @GrupoT21
